The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome (ROBOT-ACS)
Sponsor: Countess of Chester NHS Foundation Trust
This observational or N/A phase trial investigates Acute Coronary Syndrome and Bleeding and is currently completed. Countess of Chester NHS Foundation Trust leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Jul 2022 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Countess of Chester NHS Foundation Trust
- Liverpool Heart and Chest Hospital NHS Foundation Trust
- Liverpool University Hospitals NHS Foundation Trust
- St Helens & Knowsley Teaching Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .